Skip to main content

We are committed to connecting you with resources in light of the RELYVRIO®/ALBRIOZA™ updates that we announced in April 2024. For more information specific to your region, please see below.

United States Information and Resources

In the U.S., the Amylyx Care Team is no longer active. Please direct any questions to medinfo@amylyx.com.

Canada Information and Resources

ALBRIOZA is now available only to current patients under Amylyx Pharmaceuticals, Inc.’s Patient Support Program and should not be initiated in new patients. For more information on the Patient Support Program, contact 1-877-710-0711 or support@amylyxcareteam.ca. The additional information linked below is intended for Canadian residents and should be read and discussed in consultation with a healthcare professional.

English Product Monograph 
French Product Monograph 
English Health Product Risk Communication 
French Health Product Risk Communication